Articulus Surgical Raises Seed Funding to Drive Market Rollout of India-Built Surgical Robotics Platform
SUMMARY
National, 11 February 2026: Articulus Surgical, a deep-tech medical device company building an indigenous, interoperable surgical robotics ecosystem for minimally invasive soft-tissue surgery, has raised a Seed round of funding led by Kalaari Capital. The funding marks a key inflection point as the company transitions from years of product development to scaled market adoption.
Despite more than 200 million abdominal surgeries performed globally each year, robotic surgery penetration remains at around 5% worldwide and under 1% in India, underscoring a significant unmet opportunity. Articulus Surgical aims to address this gap with an India-built platform designed for high-volume procedures across diverse healthcare settings.
After years of sustained research, engineering, and clinical validation, the company’s core products are now market-ready. The capital will be used to accelerate market rollout, expand hospital deployments, strengthen surgeon training initiatives, and deepen strategic hospital partnerships across India.
Commenting on the fundraise, Saurya Mishra, Founder & CEO, Articulus Surgical, said, “This funding allows us to shift focus to scale and adoption, bringing advanced, minimally invasive surgical technology to more hospitals and surgeons, while staying true to our self-reliant Make-in-India vision with global relevance, driven by a great, young team and an unwavering focus on patient care.”
Pranav Koshal, Vice President, Kalaari Capital, added, “Accessible, high-quality healthcare remains one of the most critical whitespace opportunities in India, where millions of patients still lack access to world-class surgical care. We’re excited to back Saurya and the team at Articulus Surgical, who are building a vertically integrated, India-native platform of affordable robotic surgical systems. Their approach is focused on bringing precision, safety, and minimally invasive procedures within reach of surgeons and patients across the country precisely the kind of impact-driven innovation India needs”
Built entirely in India by a multidisciplinary team of surgeons, engineers, and scientists, the company’s flagship system, Pulsar, is a first-of-its-kind modular surgical robotics platform designed for high-volume minimally invasive procedures. Articulus Surgical has also developed Galaxi, an intelligent surgical optics robot, and Nebula, a surgical robotics simulation and training system, which is already in production and commercial deployment.
Over the next 12–18 months, Articulus Surgical plans to increase deployments across Indian hospitals, establish dedicated surgeon training centres, and focus on high-volume procedures across general surgery, gynaecology, urology, gastrointestinal surgery, and surgical oncology.
The company is backed by Gaurav Agarwal, Co-founder and Managing Director of Innvolution Healthcare, and Sandeep Daga, Managing Director of Nine Rivers Capital.
About Articulus Surgical:
Founded in 2019 by Saurya Mishra, Articulus Surgical is a deep-tech medical device company building an indigenous, interoperable surgical robotics ecosystem for minimally invasive soft-tissue surgery. The company is designed and built entirely in India by a multidisciplinary team of surgeons, engineers, and scientists, with a focus on bringing robotic precision to real-world operating rooms across diverse healthcare settings.
Articulus’ product portfolio spans the full soft-tissue robotics continuum, including its flagship modular surgical robotics system, Pulsar, the Galaxi intelligent surgical optics robot, and Nebula, a surgical robotics simulation and training platform. The systems are engineered for high-volume clinical environments and are designed to integrate seamlessly with existing hospital infrastructure, enabling adoption across hospitals of all sizes.
Guided by a strong philosophy of vertical integration, domestic manufacturing, and technological self-reliance, Articulus Surgical reduces dependency on imports by building core systems from the ground up. The company aims to improve surgical outcomes globally while strengthening India’s medical technology ecosystem.
Articulus Surgical designs, builds, and executes its innovations in India, while advancing regulatory approvals and commercial deployments across both domestic and international markets.
Note: We at scoopearth take our ethics very seriously. More information about it can be found here.
